Comments Regarding Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products Share page: Docket Number: FDA-2024-D-4689 Download Document Issues: Other Issues Related Posts Comments Comments Regarding Artificial Intelligence-Enabled Device Software Functions Apr 4, 2025 Comments Comments Regarding Enhancing Coverage of Preventative Services Under the Affordable Care Act Dec 26, 2024 Comments Comments Regarding Control of Nitrosamine Impurities in Human Drugs Dec 20, 2024
